Inflation Reduction Act Estimated to Yield Billions in Drug Savings
THURSDAY, Feb. 2, 2023 (HealthDay News) — A new simulation suggests Medicare drug savings from the Inflation Reduction Act of 2022 will be substantial, according to a study published online Jan. 27 in JAMA Health Forum.Benjamin N. Rome, M.D., from Br…
Learn MoreMaker of Diet Drug Wegovy Ramps Up Production to Meet Demand
THURSDAY, Feb. 2, 2023 (HealthDay News) – The wildly popular weight-loss drug Wegovy has become hard to find, but that could soon change.Novo Nordisk, which makes the medication, said Wednesday that it has increased production to meet demand. “We know…
Learn MoreAlternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — For patients with newly diagnosed multiple myeloma after induction treatment and autologous stem cell transplantation, maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be better than…
Learn MoreOzempic: Dieters Who Use Scarce Diabetes Drug Could Face Side Effects
WEDNESDAY, Feb. 1, 2023 (HealthDay News) — Mila Clarke started taking Ozempic in 2020 to help manage her diabetes, but was pleasantly surprised to find herself soon shedding pounds.“I was like, this is really weird because I’m not having to try very …
Learn MoreMedicare ahorrará miles de millones a EE. UU. al negociar los precios de los medicamentos
LUNES, 30 de enero de 2023 (HealthDay News) — El gobierno de EE. UU. podría ahorrar miles de millones de dólares cada año una vez Medicare comience a negociar los precios de los medicamentos en 2026, sugiere una investigación reciente.La Ley de Reduc…
Learn MorePersistent Gaps Exist in Continuity of Medication Use for Adults With Diabetes
MONDAY, Jan. 30, 2023 (HealthDay News) — A considerable proportion of adults with diabetes do not maintain continuity of use of glucose, blood pressure, or lipid medications, according to a study published online Jan. 30 in JAMA Network Open.Puneet K…
Learn MorePolypill Not Linked to Reduced Cognitive Decline in Seniors
MONDAY, Jan. 30, 2023 (HealthDay News) — A polypill (antihypertensives and a statin) does not reduce cognitive decline but is associated with reduced functional decline for adults aged 65 years and older with cardiovascular risk factors, according to…
Learn MoreMedicare Will Save U.S. Billions Negotiating Drug Prices
MONDAY, Jan. 30, 2023 (HealthDay News) — The U.S. government could save billions every year once Medicare begins negotiating drug prices in 2026, new research suggests.The Inflation Reduction Act passed by Congress last year allows Medicare to bargai…
Learn MoreCasi 1 de cada 5 adultos estadounidenses toma somníferos
MIÉRCOLES, 25 de enero de 2023 (HealthDay News) — Casi un 20 por ciento de los adultos estadounidenses usan un medicamento para que los ayude a dormir, ya sea ocasional o regularmente, reportaron el miércoles las autoridades de salud.Los somníferos, …
Learn MoreOnce-Weekly Efanesoctocog Alfa Beneficial in Severe Hemophilia A
THURSDAY, Jan. 26, 2023 (HealthDay News) — Once weekly efanesoctocog alfa provides superior bleeding prevention to prestudy prophylaxis for patients with severe hemophilia A, according to a study published in the Jan. 26 issue of the New England Jour…
Learn More
English
Spanish